By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sanofi Pasteur 

174, av. de France

Paris    75013  France
Phone: 33-1-53-77-4076 Fax: 33-1-53-77-4174



Company News
Sanofi Pasteur (SASY.PA) Release: High-Dose Influenza Vaccine With Evidence Of Superior Efficacy* In Older Adults: Now In Canada 10/13/2016 7:35:52 AM
Sanofi Pasteur (SASY.PA) Nabs $43 Million U.S. Funding to Speed Up Zika Vaccine Development 9/27/2016 6:09:07 AM
Dyadic (DYAI) Stock Tanks Amid Reports of Partnership Termination With Sanofi Pasteur (SASY.PA) 8/9/2016 6:46:55 AM
Sanofi Pasteur (SASY.PA) Ships First Of Its 2016-2017 Seasonal Influenza Vaccine Doses In United States 7/26/2016 6:28:12 AM
New Four-Strain Influenza Vaccine, VaxigripTetra, Regulatory Dossier From Sanofi Pasteur (SASY.PA) Now Approved In Europe 6/23/2016 6:21:27 AM
Terrapinn Release: Experts From Merck & Co. (MRK), GlaxoSmithKline (GSK), Pfizer (PFE), Sanofi Pasteur (SASY.PA) And More To Debate Breakthroughs For Vaccines For Ebola, Zika And Cancer. 3/7/2016 10:20:07 AM
Sanofi Pasteur (SASY.PA) Release: High-Dose Influenza Vaccine Recognized As A New Option With Demonstrated Superior Efficacy* For Adults 65 Years And Older 2/24/2016 9:24:26 AM
The Human Vaccines Project Welcomes Sanofi Pasteur (SASY.PA) To Its Global Consortium 1/15/2016 1:22:28 PM
Sanofi Pasteur (SASY.PA)'s Dengue Vaccine Approved in the Philippines 12/22/2015 7:36:16 AM
Sanofi Pasteur (SASY.PA) to Launch World's First Dengue Vaccine in Mexico 12/10/2015 5:31:32 AM